Abstract #0278

Hyperpolarized Carbon-13 Metabolic Imaging of Pediatric Patients with Brain Tumors: Initial Experience

Ilwoo Park¹, Adam Autry², Yiran Chen², Jeremy Gordon², Lucas Carvajal², Hsin-Yu Chen², Robert Bok², Mark Van Criekinge², James Slater², Cassie Kline-Nunnally³, Peder Larson², Daniel Vigneron², Janine Lupo², Duan Xu², and Sabine Mueller⁴

¹Radiology, Chonnam National University College of Medicine, Gwanju, Republic of Korea, ²Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States, ³Pediatric Hematology-Oncology, University of California San Francisco, San Francisco, CA, United States, ⁴Neurology, Neurosurgery and Pediatrics, University of California San Francisco, San Francisco, CA, United States

This study applied hyperpolarized ¹³C metabolic imaging in pediatric populations for the first time to our knowledge. Dynamic ¹³C data were acquired following injection of hyperpolarized [1-¹³C]pyruvate in the first 3 pediatric patients with brain tumors as part of an ongoing trial (PNOC011,NCT02947373). No adverse effects were observed for these 3 patients. Pyruvate, lactate and bicarbonate signals with high SNR were detected in the pediatric brain. These preliminary results demonstrated the feasibility of using HP [1-¹³C]pyruvate for assessing in vivo metabolism from pediatric patients with brain tumors and support ongoing investigation of this technology in pediatric patients.

This abstract and the presentation materials are available to members only; a login is required.

Join Here